Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
Despite China’s overall economy coming down with a bad cold last year, its EV players are upstaging the world’s most valuable auto company.
With military conflict continuing across the globe, and the world’s superpowers locked in a stare-down, it’s not easy being a global business
Apple — admitting no wrongdoing — has agreed to settle a class-action lawsuit that alleged Siri recorded users’ private conversations.